Results at 24 Weeks: Notably, the 0.5 mg group experienced the greatest overall fat loss with better tolerance and fewer side effects than the 1 mg dose making it the most clinically relevant dose for most users
References PubMed Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds Current Pharmaceutical Design (PubMed) Stable gastric pentadecapeptide BPC-157: novel therapy in gastrointestinal tract PMC Utilizing developmentally essential secreted peptides such as Thymosin Beta-4 for regenerative therapies Annals of the New York Academy of Sciences (PubMed) Thymosin beta 4 and wound healing: new ideas
B12 plays an essential role in enhancing the metabolic function of the cells, this nutrient can boost energy, improve memory and help prevent heart disease
Severe gastrointestinal conditions: Those with delayed gastric emptying, gastroparesis, or chronic GI dysmotility may experience exacerbated symptoms due to the drugs action on gastric motility
Maintain at least 2 inches (5 cm) between injection sites
FAQ'S FAQ'S Results vary by treatment, but you may see changes in energy and mood within a few days